Prediction of functional recovery of viable myocardium after delayed revascularization in postinfarction patients Accuracy of dobutamine stress echocardiography and influence of long-term vessel patency by Monin, Jean-Luc et al.
Prediction of Functional Recovery
of Viable Myocardium After Delayed
Revascularization in Postinfarction Patients
Accuracy of Dobutamine Stress
Echocardiography and Influence of Long-Term Vessel Patency
Jean-Luc Monin, MD,* Je´roˆme Garot, MD,* Marielle Scherrer-Crosbie, MD,* Jean Rosso, MD,*
Anne-Marie Duval-Moulin, MD,* Patrick Dupouy, MD,† Emmanuel Teiger, MD,† Alain Castaigne, MD,*
Jean-Claude Cachin, MD,* Jean-Luc Dubois-Rande, MD, PHD,* Pascal Gueret, MD, FACC*
Creteil, France
OBJECTIVES We sought to evaluate Dobutamine stress echocardiography (DSE) for predicting recovery of
viable myocardium after revascularization with cineangiography as a gold standard for left
ventricular (LV) function. We studied the influence of late vessel reocclusion on regional LV
function.
BACKGROUND Dobutamine stress echocardiography is a well established evaluation method for myocardial
viability assessment. In previous studies the reference method for assessing LV recovery was
echocardiography; long-term vessel patency has not been systematically addressed.
METHODS Sixty-eight patients with a first acute myocardial infarction (AMI) and residual stenosis of the
infarct related artery (IRA) underwent DSE (mean 6 standard deviation) 21 6 12 days after
AMI to evaluate myocardial viability. Revascularization of the IRA was performed in 54
patients by angioplasty (n 5 43) or bypass grafting (n 5 11). Coronary angiography and LV
cineangiography were repeated at four months to assess LV function and IRA patency.
RESULTS Sensitivity and specificity of DSE for predicting myocardial recovery after revascularization
were 83% and 82%. In the case of late IRA patency, specificity increased to 95%, whereas
sensitivity remained unchanged. In the 16 patients with myocardial viability and late IRA
patency, echocardiographic wall motion score index decreased after revascularization from
1.83 6 0.15 to 1.36 6 0.17 (p 5 0.0001), and left ventricular ejection fraction (LVEF)
increased from 0.52 6 0.06 to 0.57 6 0.06 (p 5 0.0004), whereas in five patients, reocclusion
of the IRA prevented improvement of segmental or global LV function despite initially viable
myocardium.
CONCLUSIONS Dobutamine stress echocardiography is reliable to predict recovery of viable myocardium after
revascularization in postinfarction patients. Late reocclusion of the IRA may prevent LV
recovery and influence the accuracy of DSE. (J Am Coll Cardiol 1999;34:1012–9) © 1999
by the American College of Cardiology
In patients with acute myocardial infarction (AMI), re-
gional left ventricular (LV) dysfunction may represent
necrotic or viable myocardium. When viable myocardium is
supplied by a vessel without significant stenosis, progressive
functional recovery may occur (1). However, viable myocar-
dium supplied by a critically stenosed vessel may benefit
from delayed revascularization and show functional recovery
of the involved segments (2,3). Dobutamine stress echocar-
diography (DSE) has the potential to detect viable myocar-
dium early after myocardial infarction (4–8) and to predict
functional recovery of viable myocardium after revascular-
ization in patients with chronic coronary artery disease
(CAD) (9–16). All previous studies evaluating DSE for
myocardial viability have focused on echocardiography as
the reference standard to evaluate long-term improvement
of segmental LV function. In these studies, echocardiogra-
phy was used for assessment of inotropic reserve and as the
reference for functional improvement. Furthermore, the
effects of long-term patency of the revascularized vessel on
functional recovery of viable segments have not been spe-
cifically addressed, whereas it has been recently demon-
strated that reocclusion of the infarct-related artery (IRA)
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may prevent viable myocardium from regaining contractility
after revascularization (17,18).
The aim of this study was to evaluate the ability of DSE
to predict regional LV function recovery after delayed
revascularization of the IRA in patients after AMI using
serial LV angiography as the gold standard for myocardial
recovery, and to determine the influence of long-term
patency of the IRA on segmental LV function and diag-
nostic accuracy of DSE.
METHODS
Patient population. Sixty-eight patients with a first myo-
cardial infarction were prospectively included in this study
between May 1995 and May 1997. The inclusion criteria
were:
1) diagnosis of a first Q-wave AMI, with significant initial
electrocardiographic ST segment elevation (.1 mm)
and a significant creatine kinase MB isoenzyme eleva-
tion,
2) segmental asynergy at early LV angiography,
3) clearly identified IRA with a significant residual stenosis
($70% diameter reduction) or complete occlusion, suit-
able for revascularization by either percutaneous trans-
luminal coronary angioplasty (PTCA) or coronary artery
bypass grafting (CABG),
4) informed consent obtained from each patient.
Exclusion criteria were poor echogenicity, significant
stenosis ($50%) of the left main coronary artery, emergency
revascularization, unstable angina, atrial fibrillation or ven-
tricular tachycardia that occurred more than 48 h after
AMI.
Study protocol. Dobutamine stress echocardiography was
performed between 15 and 21 days after AMI. Delayed
revascularization of the IRA was attempted in all patients by
PTCA or CABG regardless of DSE results. Regional and
global systolic LV function were assessed by LV angiogra-
phy performed immediately before revascularization and at
four-month follow-up examination. Patency of the IRA was
assessed by a repeat coronary angiogram at follow-up. All
patients received aspirin (250 mg/day) and beta-adrenergic
blocking agents if tolerated. Angiotensin-converting en-
zyme (ACE) inhibitors were given within the first week of
AMI when the first angiographic ejection fraction was
,40%. Medications were not modified after revasculariza-
tion and the dosage was kept constant until the four-month
follow-up examination.
DSE. All patients underwent dobutamine stress echocar-
diography with commercially available equipment (Acuson
[Mountain View, California] 128 XP-10 c with 2.5 to
4 Mhz transducers). Beta-blockers were withdrawn for at
least 48 h before DSE and reintroduced immediately after
the test. Other medications (including calcium-channel
blockers, nitrates, ACE inhibitors, diuretics, aspirin and
anticoagulants) were continued. Four echographic views
(parasternal long and short axis, apical four and two cham-
bers) were digitized on-line with an automated acquisition
system (Image Vue DCR 1.41, Nova Microsonics [Mah-
wah, New Jersey) at baseline, low and peak dose of dobut-
amine. All digitized loops were stored on 5 1/4 in. optical
disks for subsequent blind analysis. After baseline imaging,
continuous intravenous infusion of dobutamine was started
at 5 mg/kg/min and increased by steps of 5 mg/kg/min every
5 min up to a maximum dose of 40 mg/kg/min. Atropine
(0.25 to 1 mg) was added if necessary to reach 85% of
maximal predicted heart rate. Electrocardiogram (ECG),
blood pressure and heart rate were monitored at the end of
each stage. Criteria for terminating the study were:
1) reaching $85% of maximal predicted heart rate,
2) worsening of wall motion in 2 contiguous myocardial
segments,
3) fall of systolic blood pressure .30 mm Hg,
4) chest pain with ST segment depression $1 mm,
5) frequent ventricular or supraventricular ectopic beats.
Repeat rest echocardiography was performed at follow-up
examination, and the same four views were digitized for
off-line analysis.
Echocardiographic analysis. All DSE studies and
follow-up echocardiograms were analyzed off-line by two
independent observers blinded to patients’ clinical and
angiographic data. The LV was divided into 16 segments
for wall motion analysis according to the recommendations
of the American Society of Echocardiography (19). Myo-
cardial thickening of each segment was graded visually using
a semiquantitative score (19): 1 5 normal wall motion; 2 5
hypokinesia (decreased systolic wall thickening); 3 5 aki-
nesia; 4 5 dyskinesia (outward wall motion or systolic wall
thinning). Myocardial viability in each segment was defined
by a decrease of the wall motion score of .1 point, for
example, from 3 to 2 (or 1), or from 2 to 1, whereas decrease
Abbreviations and Acronyms
ACE 5 angiotensin-converting enzyme
AMI 5 acute myocardial infarction
ANOVA 5 two-way analysis of variance
BP 5 blood pressure
CABG 5 coronary artery bypass grafting
CAD 5 coronary artery disease
DSE 5 dobutamine stress echocardiography
ECG 5 electrocardiogram
IRA 5 infarct-related artery
LAD 5 left anterior descending
LV 5 left ventricle or ventricular
LVEF 5 left ventricular ejection fraction
PTCA 5 percutaneous transluminal coronary
angioplasty
SD 5 standard deviation
WMSI 5 wall motion score index
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in wall motion score from 4 to 3 was not considered as
viability. A wall motion score index (WMSI) was calculated
for each stage as follows (19): WMSI 5 sum of all segment
scores divided by the number of scored segments. Myocar-
dial viability was defined for each patient by the two
following criteria:
1) improvement of myocardial thickening during DSE in
$2 adjacent segments located in the infarct zone, and
2) decrease of the LV WMSI $20%, as previously pro-
posed (9).
Interobserver variability was assessed in 20 patients
(1,247 segments). Differences between the two observers
were resolved by consensus.
Assessment of LV function by cineangiography. The
reference method for assessment of segmental and global
LV systolic function was LV cineangiography performed
immediately before revascularization and at four-month
follow-up examination. Systolic function in the infarct zone
and LV global ejection fraction were calculated from the
angiographic data by one independent observer blinded to
clinical and echocardiographic data. End-diastolic and end-
systolic volume indexes (ml/m2) as well as left ventricular
ejection fraction (LVEF) were calculated by the area-length
method (20). Regional wall motion was expressed as radial
shortening fraction of 13 anatomic wall segments by the
center-line method in the right-anterior oblique view as
previously described (18). The normal range for ejection
fraction and for each radial shortening segment was deter-
mined from ventriculograms performed in 40 subjects
matched for age and gender with atypical chest pain and
normal coronary angiograms without other cardiovascular
disease. To compare values for regional anterior or posterior
wall motion with normal values and values at follow-up
angiography, a standardized motion index expressed in units
of standard deviation (SD) from the mean in control
subjects was calculated ([% shortening of patient’s segment
2 mean of the same normal segment]/SD of the normal
segment). The wall motion for an individual segment was
considered normal if the value was within two SDs of the
equivalent mean value in controls. Regional wall motion was
considered to be hypokinetic if the wall motion of at least
three segments was #2 SDs below the normal range. For a
given territory (segments from 1 to 6 or from 7 to 13), an
average of the three most hypokinetic segments was calcu-
lated and used for statistical comparisons.
Follow-up angiography. Coronary and LV angiograms
were obtained at follow-up in all 52 surviving patients. The
infarct vessel was considered to be reoccluded at four-
months in the case of TIMI grade 0 or 1. In the case of
restenosis $50% but TIMI grade 2 or 3, the artery was
classified as patent. Surgical revascularization was consid-
ered successful if the graft did not reveal a $50% stenosis.
Recovery of systolic regional LV function at follow-up
examination was defined as an improvement of WMSI $1
SD for all three aforementioned initially most hypokinetic
segments.
Statistical analysis. Data in the text, tables and figures are
expressed as mean 6 SD. Sensitivity, specificity and positive
and negative predictive values of DSE were calculated
according to the standard formulae. Two-way analysis of
variance (ANOVA) for repeated measures was performed to
assess differences in continuous variables (WMSI and
LVEF) between patients with and without myocardial
viability by DSE and between patients with and without
IRA patency at follow-up examination. Paired Student t test
was used when appropriate. Differences between propor-
tions were assessed by chi-square analysis. Correlations were
obtained by the linear regression method. A p value ,0.05
was considered to indicate statistical significance.
RESULTS
Patient data. Sixty-eight patients were initially enrolled.
Sixteen patients were excluded from analysis for the follow-
ing reasons: 3 deaths (1 patient before revascularization and
2 patients after CABG), poor echogenicity in 2 patients, 11
patients with initially occluded IRA and failure to reopen
the vessel by PTCA. Finally, 52 patients (48 men, 4 women,
mean age 55 6 10 years) completed the study. Location of
AMI was anterior in 28 and inferior in 24 patients.
Dobutamine stress echocardiography and revascularization
were performed 21 6 11 days and 28 6 17 days after AMI,
respectively. Forty-three patients underwent successful
PTCA including three patients with stent implantation.
The nine remaining patients underwent CABG without
clinical, ECG or biochemical signs of perioperative myo-
cardial infarction. All patients underwent follow-up studies
110 6 12 days after revascularization, including a rest
echocardiogram, coronary angiography and LV angiogra-
phy. Medical regimens were not modified throughout the
study-period.
Interobserver reproducibility for DSE and LV angiogra-
phy. Interobserver reproducibility for echocardiographic
wall motion score was assessed by comparing the score given
by the two independent observers for each of the 16
segments in 20 randomly selected patients at baseline,
low-dose 1, low-dose 2 and peak dose of dobutamine.
Comparison was possible for 1,247 scored segments. The
same score (from 1 to 4) was accorded by the two observers
to 1,107 segments (agreement in 89% of cases). A 1-point
difference in score was noted for 134 segments and a 2-point
difference was noted in only six segments (interobserver
disagreement in 11% of segments).
Interobserver reproducibility for the measurement of
angiographic LVEF was also assessed in 20 randomly
selected patients. The mean difference in LVEF between
the two observers was 0.95 6 0.59% and was not significant
(p 5 0.22). Linear regression showed reproducible results
1014 Monin et al. JACC Vol. 34, No. 4, 1999
Viability by DSE in Light of Vessel Patency October 1999:1012–9
and a good correlation between the two measurements (y 5
1.01x 1 0.59, r 5 0.95, p , 0.0001).
Correlation at follow-up examination between echocar-
diography and cineangiography. Follow-up echocardio-
graphic data were directly compared with follow-up angio-
graphic data to correlate changes in wall motion and LVEF
at angiography and changes in echocardiographic WMSI.
There was no correlation between changes in angiographic
LVEF and changes in echographic WMSI. The correlation
between the changes in regional wall motion in units of
standard deviation by angiography and the changes in
WMSI by echography was statistically significant: r 5 0.53,
p 5 0.0001.
DSE studies. Three patterns of segmental wall motion
during DSE were observed in infarct territory:
1) sustained improvement at low and high doses of dobut-
amine in 3 patients,
2) biphasic response in 18 patients, with improved wall
thickening at low-dose dobutamine followed by deteri-
oration at higher doses,
3) no change in segmental wall motion in 31 patients.
Biphasic response or sustained improvement at DSE
were considered to be an indicator of viable myocardium.
The mean peak dose of dobutamine was 25 6 10 mg/kg/
min for the whole group. In five patients, the test was
stopped at 10 mg/kg/min (frequent ectopic ventricular beats
in four cases and achievement of maximal predicted heart
rate in one). The reasons for terminating the study were
reaching 85% of maximal predicted heart rate in 21 patients,
worsening of segmental wall motion in 20 patients accom-
panied by chest pain in 5 cases, arrythmias in 11 patients
(frequent ectopic beats in 9 patients and nonsustained VT in
2 patients). The mean dose of dobutamine at which patients
exhibited improvement of systolic wall thickening was 9.0 6
3 mg/kg/min. At this dose, there was no significant accel-
eration of heart rate (68 6 9 vs. 66 6 8 beats/min at rest)
and no significant change in blood pressure (BP) (systolic
BP 5 116 6 16 vs. 112 6 13 mm Hg).
Reocclusion of the IRA at follow-up examination. All
grafts were patent at follow-up examination in the patients
who underwent CABG. In the 43 patients who underwent
PTCA, the IRA was found to be reoccluded in 12 cases
(28%) at follow-up examination. The reocclusion rate was
higher in patients with initial occlusion of the IRA when
compared with patients in whom IRA was initially patent
(respectively 9/19 vs. 3/24, p , 0.001).
Diagnostic accuracy of DSE in light of vessel patency.
Myocardial viability in the infarct zone was diagnosed by
DSE in 21/52 patients (40%), whereas 31 patients had no
inotropic reserve. Functional recovery after revascularization
was observed in 18/52 patients (35%) at follow-up angiog-
raphy and 34 patients exhibited fixed dysfunction.
Among 18 patients with a biphasic response at DSE,
recovery of the infarct zone at follow-up examination was
present in 15 (true positives); all of them had a patent IRA
at follow-up (Fig. 1). Three patients with a biphasic
response showed no recovery at follow-up examination
(false positives). In the three latter patients, two patients
showed inotropic reserve of the inferior wall at DSE and
one patient showed improved wall motion of the anterior
wall and apex. All three patients had a reoccluded IRA at
follow-up examination. None of the three patients with
sustained improvement at DSE showed any recovery of the
infarct-zone at follow-up examination (false positives). All
had inotropic reserve of the anterior wall at DSE and IRA
was patent at follow-up examination in 1⁄3 of the patients.
Among the 31 patients with no change in segmental wall
motion at DSE, functional recovery occurred in three
patients (false negatives) in whom the IRA was patent at
follow-up. Twenty-eight patients without inotropic reserve
did not show any functional improvement (true negatives)
despite a patent IRA at follow-up examination in 21
patients. Thus, six patients were classified as false positives
for DSE. Of these, five patients had a reoccluded IRA at
follow-up procedure.
For the whole group of patients, the sensitivity, specificity
and positive and negative predictive values of DSE to
predict functional recovery of viable myocardium after
revascularization were 83%, 82%, 71% and 90%, respec-
tively.
In the subgroup of patients with a patent IRA at
follow-up procedure, the specificity of DSE increased from
82% to 95% and the positive predictive value increased from
71% to 93%, whereas the sensitivity was unchanged (83%)
and the negative predictive value slightly decreased from
90% to 82%.
All 15 patients showing a biphasic response at DSE and
a patent IRA at follow-up had a functional improvement in
the infarct zone at follow-up procedure. In these patients
Figure 1. Three patterns observed at dobutamine echocardiogra-
phy and relationship between patency of infarct-related vessel at
follow-up examination and recovery of LV function. Biphasic 5
biphasic response; No recov. 5 no functional recovery; Patent 5
patent infarct vessel at follow-up; Recov 5 functional recovery;
Reocc 5 reoccluded infarct vessel at follow-up; Sustained imp. 5
sustained improvement.
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the positive predictive value of a biphasic response was
100%.
Influence of IRA patency at follow-up procedure on
regional and global LV function. Vessel patency and echo-
cardiographic WMSI. Baseline WMSI was not significantly
different between the patients with patent versus occluded
IRA at follow-up examination and between the patients
with functional recovery versus fixed dysfunction at
follow-up examination (Table 1). The results of ANOVA
for the evolution of WMSI (baseline vs. follow up) showed
no significant effect of myocardial viability alone (p 5 0.52)
and a slight but significant effect of late vessel patency alone
(p 5 0.036); the interaction of viability and late vessel
patency was highly significant (p 5 0.0089). Wall motion
score index decreased after revascularization in the 21
patients with myocardial viability at DSE (from 1.79 6 0.16
to 1.44 6 0.22, p 5 0.0001, Fig. 2) and in the 16 patients
with myocardial viability and a patent IRA at follow-up
examination (from 1.83 6 0.15 to 1.36 6 0.17, p 5 0.0001,
Fig. 2). Conversely, in the five patients with viable myocar-
dium at DSE and reoccluded IRA at follow-up examina-
tion, there was no significant change in WMSI at follow-up
(from 1.68 6 0.14 to 1.69 6 0.18, p 5 0.9, Fig. 2). In the
remaining patients without viability at DSE, no significant
change in WMSI was noted after revascularization (from
1.88 6 0.27 to 1.79 6 0.27, p 5 0.1).
Influence of vessel patency on LVEF. Left ventricular
ejection fraction at baseline was significantly lower in
patients without viability when compared with patients with
viability at DSE (43 6 11% vs. 50 6 9%, respectively, p 5
Table 1. Clinical, Echocardiographic and Angiographic Characteristics of the Study Population
Patent IRA at FU Occluded IRA at FU p Recovery at FU No Recovery p
Patients (n) 40 12 18 34
Age (yr) 56 6 10 53 6 12 NS 57 6 9 55 6 11 NS
Infarct location
Anterior AMI n 5 20 n 5 8 ,0.001 n 5 8 n 5 20 0.004
Inferior AMI n 5 20 n 5 4 n 5 10 n 5 14
Peak CK (UI/l) 3786 6 2020 2930 6 1034 NS 2803 6 1178 3968 6 2032 NS
Baseline WMSI 1.82 6 0.19 1.94 6 0.33 NS 1.77 6 0.16 1.89 6 0.26 NS
Angiographic
LVEF (%) 47 6 9 40 6 15 0.03 51 6 7 43 6 11 0.01
Infarct-related vessel
LAD (n) 20 8 * 8 20 §
RCA (n) 16 4 ** 7 13 §§
Cx (n) 4 0 3 1
Initial status of IRA
Occluded (n) 13 9 0.001 6 16 0.004
Stenosis $70% (n) 27 3 12 18
*p 5 0.02 vs. RCA; p 5 0.0001 vs. Cx; **p 5 0.0001 vs. Cx; §p 5 0.04 vs. RCA; p 5 0.0001 vs. Cx; §§p 5 0.0001 vs. Cx.
AMI 5 acute myocardial infarction; CK 5 creatine kinase; Cx 5 left circumflex artery; FU 5 follow-up; IRA 5 infarct related artery; LAD 5 left anterior descending artery;
LVEF 5 left ventricular ejection fraction; RCA 5 right coronary artery; WMSI 5 wall motion score index.
Figure 2. Influence of long-term vessel patency on WMSI in viable patients after revascularization. FU 5 follow-up; Viable all 5 all
patients with myocardial viability at DSE; Viable 1 patent 5 patients with viable myocardium at DSE and patent IRA at follow-up;
Viab 1 reocc 5 patients with viable myocardium at DSE and a reoccluded IRA at follow-up; WMSI: echographic wall motion score
index. Data are shown as mean value 6 SD. *p 5 0.0001. Solid bars 5 baseline WMSI; open bars 5 follow-up WMSI.
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0.02). In patients with fixed dysfunction or reocclusion of
the IRA at follow-up procedure, LVEF at baseline was
significantly lower and the IRA was more frequently the left
anterior descending (LAD) (Table 1). The results of
ANOVA for the evolution of LVEF (baseline vs. follow-
up) showed no significant effect of myocardial viability alone
(p 5 0.21) and no significant effect of late vessel patency
alone (p 5 0.67); the interaction of viability and late vessel
patency was significant (p 5 0.035). When considering the
whole population, revascularization of the culprit vessel led
to a slight increase of LVEF (from 46 6 11% to 49 6 11%,
p 5 0.01). Left ventricular ejection fraction also increased
slightly after revascularization (from 50 6 9% to 53 6 9%,
p 5 0.02, Fig. 3) for the 21 patients with viable myocardium
at DSE. A greater increase in LVEF (from 52 6 6% to
57 6 6%, p 5 0.0004) was noted at follow-up examination
for the 16 patients with viability at DSE and a patent IRA
at follow-up examination, whereas no significant improve-
ment (from 42 6 11% to 42 6 9%, p 5 0.96) occurred in
the five patients with viability at DSE and occluded IRA at
follow-up examination (Fig. 3).
DISCUSSION
In this study, we demonstrated that, in patients with a first
Q-wave AMI, functional improvement after delayed revas-
cularization of the IRA was accurately predicted by DSE
performed two weeks after AMI with LV cineangiography
as a gold standard for the assessment of functional recovery.
The systematic evaluation of patency of the IRA at
follow-up examination showed that regional LV function
improvement, and therefore the diagnostic accuracy of
DSE, may be influenced by late reocclusion of the infarct
vessel. Our population fulfilled the criteria of a first Q-wave
AMI with decreased global systolic function (mean angio-
graphic LVEF at the acute phase 546 6 11%) and a severe
residual stenosis of the IRA. In these patients, the detection
of viable but jeopardized myocardium is important to select
patients who can benefit from coronary revascularization,
thus expecting functional improvement of segmental wall
motion in the infarct zone (4,9). The need for revascular-
ization to achieve functional recovery of viable but jeopar-
dized myocardium after AMI has already been pointed out
(4,21). In the study reported by Pie´rard et al. (21), most of
the patients with viable myocardium but severely reduced
perfusion did not show any improvement at 9 6 7 months
follow-up examination; this can be explained by the absence
of revascularization of the IRA in most cases. Barilla et al.
(4) also reported on myocardial viability assessed by DSE in
the first week after an anterior AMI. The functional
improvement of viable segments supplied by stenotic arter-
ies was greater in the patients who underwent revascular-
ization compared with patients who did not. Thus, our data
confirm, in a homogeneous population of patients with
recent myocardial infarction and viable but jeopardized
myocardium at DSE, that delayed revascularization of the
culprit vessel leads to a significant improvement of regional
and global systolic LV function.
Reference method for segmental and global LV systolic
function. All previous studies evaluating DSE to predict
functional improvement of segmental myocardial asynergy
have used echocardiography as the reference method for the
evaluation of LV function at baseline and during follow-up
examination (4–16). In the current study, global and re-
gional LV function were assessed by cineangiography as a
gold standard for functional improvement, regardless of
echocardiographic data. Echocardiographic and angio-
graphic data were analyzed by independent investigators
blinded to the results of the alternative technique. The use
of single-plane ventriculography to assess functional recov-
ery could appear as a limitation by missing the recovery of
segments outside the viewing plane (i.e., the septum or
lateral wall). The three patients with sustained improvement
Figure 3. Influence of long-term vessel patency on global LVEF in viable patients after revascularization. LVEF 5 left ventricular ejection
fraction; Viable all 5 all patients with myocardial viability at DSE; Viable 1 patent 5 patients with viable myocardium at DSE and patent
IRA at follow-up; Viab 1 reocc 5 patients with viable myocardium at DSE and a reoccluded IRA at follow-up. Data are shown as mean
value 6 SD. *p 5 0.02, **p 5 0.0004. Solid bars 5 baseline LVEF; open bars 5 follow-up LVEF.
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at DSE who did not recover at follow up showed regional
wall motion improvement of the anterior wall and the apex
that are well imaged by the right-anterior oblique position
at ventriculography. The three false positive patients with a
biphasic response at DSE had inotropic reserve of the
inferior (two cases) or anterior wall (one case) that are also
well imaged by single-plane ventriculography. These find-
ings may overcome the theoretical drawback that functional
recovery in other segments could have been missed because
of single-plane imaging.
Influence of infarct-vessel patency. Only a few studies
dealing with the evaluation of myocardial viability by DSE
have assessed the long-term patency of the revascularized
vessels. Arnese et al. (13) reported angiographic data re-
garding coronary bypass graft patency in only 14/38 pa-
tients. Watada et al. (22) have evaluated the diagnostic value
of DSE for predicting functional recovery of viable myocar-
dium after AMI, but the infarct vessel was patent without
residual stenosis in all cases at the time of DSE and at
25-day follow-up examination, indicating stunned rather
than jeopardized myocardium in case of viability. In this
study, all patients presented a severe stenosis or occlusion of
the IRA at the time of DSE, and follow-up coronary
angiograms were available in all cases. Our results clearly
demonstrate that functional recovery after revascularization
of viable but jeopardized myocardium was dependent on the
status of the IRA at follow-up examination. In the patients
with viable myocardium, regional systolic function as well as
global ejection fraction improved after revascularization only
if the IRA was patent at follow-up procedure, whereas in
the case of late reocclusion of the IRA, the benefit of
revascularization was lost despite the presence of initially
viable myocardium at DSE. The diagnostic accuracy of
DSE for predicting long-term recovery of LV function after
revascularization may be influenced by late reocclusion of
the IRA. In this study, we showed that in the patients with
a patent IRA at follow-up procedure, the specificity and
positive predictive value of DSE in predicting functional
improvement increased (from 82% to 95% and from 71% to
93%, respectively), with only a slight decrease in the
negative predictive value (from 90% to 82%). It is interest-
ing to note that, in patients with a biphasic response at DSE
and a patent IRA at follow-up procedure, the positive
predictive value of DSE for functional recovery was 100%.
These findings may suggest that, in patients with a biphasic
response at DSE and a lack of subsequent improvement
after revascularization, reocclusion of the IRA could explain
the lack of functional recovery. Thus we suggest that the
specificity and positive predictive value of DSE for predict-
ing LV function recovery may be influenced by late reoc-
clusion of the IRA. Previous studies have assessed the
impact of late reocclusion of the IRA on regional LV
function (17,18). Meijer et al. (17) evaluated the long-term
patency of the IRA after thrombolysis in a subset of patients
from the APRICOT study. Reocclusion of the IRA oc-
curred in 26% of patients who showed no regional or global
improvement of systolic LV function and a significant
increase in LV indexed volumes. Conversely, improvement
of LVEF and no significant LV remodeling occurred in
patients with anterior AMI and a patent artery at follow-up
examination. Garot et al. (18) have reported similar results
in patients who underwent successful delayed PTCA of
occluded IRA after AMI. In this study, regional and global
LV systolic function improved without significant LV
remodeling in patients with a patent IRA at four-month
follow-up examination, in contrast with patients with a
reoccluded vessel. However, despite the presence of viable
myocardium, improvement of LV function was not consis-
tently observed after revascularization because of late reoc-
clusion of the IRA.
Frequency of myocardial viability. In this study, the
presence of myocardial viability was demonstrated by DSE
in 40% of the patients. In other studies (4,6), the proportion
of inotropic reserve in patients assessed by DSE in the first
week after AMI was higher than 70%, but in these studies
the very short delay between AMI and DSE probably led to
the detection of mainly stunned myocardium that is able to
recover spontaneously within two weeks (23). Barilla et al.
(4) reported 95% of dobutamine-responsive patients in a
selected population of patients mainly with non-Q wave
infarction. Our population is more likely to be compared
with patients presenting chronic CAD (9,11) in whom the
proportion of dobutamine-responsive patients is about 50%,
which is comparable to our results.
Study limitations. Semi-quantitative analysis of segmental
wall motion by WMSI during stress echocardiography
could appear as a limitation. Nevertheless, the complete
validation of DSE for the detection of myocardial viability is
widely accepted. Furthermore, our results showed a fairly
good correlation between the two observers for the echo-
cardiographic segmental wall motion analysis. Because
quantitative automated techniques for echocardiographic
assessment of regional systolic function are not fully vali-
dated, semiquantitative assessment still remains the refer-
ence method in the clinical setting.
In our experience, the reocclusion rate of the IRA during
follow-up procedure remains the major limitation of a
strategy of delayed revascularization of the culprit vessel
after AMI. In this study, the reocclusion rate at follow-up
procedure in the case of occluded IRA at baseline was 47%,
considering the fact that we performed mainly a standard
balloon technique for the angioplasty procedure. It is likely
that stent implantation may lead to a lower reocclusion rate
in such patients.
CONCLUSIONS
Our results showed that DSE is a reliable tool to detect
myocardial viability after AMI and to predict LV functional
improvement after delayed revascularization of the culprit
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vessel. When considering the long-term angiographic status
of the IRA, this study demonstrates that functional recovery
of viable myocardium may be prevented by the late reocclu-
sion of the IRA, and that the diagnostic value of DSE to
predict functional improvement may be influenced by the
late reocclusion of the culprit vessel.
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